Anticancer Potential of Flavonoids: An Overview with an Emphasis on Tangeretin

被引:23
|
作者
de Luna, Francisco Caninde Ferreira [1 ]
Ferreira, Wallax Augusto Silva [1 ]
Casseb, Samir Mansour Moraes [2 ]
de Oliveira, Edivaldo Herculano Correa [1 ,3 ]
机构
[1] Evandro Chagas Inst IEC, Lab Cytogenom & Environm Mutagenesis, Environm Sect SEAMB, BR 316,KM 7 S N, BR-67030000 Ananindeua, Brazil
[2] Fed Univ Para, Oncol Res Ctr, BR-66073000 Belem, Brazil
[3] Fed Univ Para UFPA, Inst Exact & Nat Sci, Fac Nat Sci, Rua Augusto Correa 01, BR-66075990 Belem, Brazil
关键词
flavonoids; tangeretin; cancer; anti-cancer; anti-proliferative; anti-metastatic; BREAST-CANCER CELLS; OXIDATIVE STRESS; IN-VITRO; EPIGENETIC MODIFICATIONS; CITRUS FLAVONOIDS; HUMAN-MELANOMA; UP-REGULATION; CYCLE ARREST; APOPTOSIS; INHIBITION;
D O I
10.3390/ph16091229
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Natural compounds with pharmacological activity, flavonoids have been the subject of an exponential increase in studies in the field of scientific research focused on therapeutic purposes due to their bioactive properties, such as antioxidant, anti-inflammatory, anti-aging, antibacterial, antiviral, neuroprotective, radioprotective, and antitumor activities. The biological potential of flavonoids, added to their bioavailability, cost-effectiveness, and minimal side effects, direct them as promising cytotoxic anticancer compounds in the optimization of therapies and the search for new drugs in the treatment of cancer, since some extensively antineoplastic therapeutic approaches have become less effective due to tumor resistance to drugs commonly used in chemotherapy. In this review, we emphasize the antitumor properties of tangeretin, a flavonoid found in citrus fruits that has shown activity against some hallmarks of cancer in several types of cancerous cell lines, such as antiproliferative, apoptotic, anti-inflammatory, anti-metastatic, anti-angiogenic, antioxidant, regulatory expression of tumor-suppressor genes, and epigenetic modulation.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] A mechanistic updated overview on Cepharanthine as potential anticancer agent
    Wang, YingZheng
    Wang, Tong
    Wang, HuaXin
    Liu, WeiDong
    Li, Xiao
    Wang, XiaoYan
    Zhang, YaNan
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [22] Hydroxamic acid hybrids as the potential anticancer agents: An Overview
    Liu, Wenhua
    Liang, Yuchen
    Si, Xiaoyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 205
  • [23] Tangeretin: A Biologically Potential Citrus Flavone
    Agrawal, Krishn Kumar
    Murti, Yogesh
    CURRENT TRADITIONAL MEDICINE, 2022, 8 (04)
  • [24] Flavonoids as promising anticancer therapeutics: Contemporary research, nanoantioxidant potential, and future scope
    Gupta, Mukta
    Ahmad, Javed
    Ahamad, Javed
    Kundu, Snehashis
    Goel, Archit
    Mishra, Awanish
    PHYTOTHERAPY RESEARCH, 2023, 37 (11) : 5159 - 5192
  • [25] Anticancer activity of flavonoids accompanied by redox state modulation and the potential for a chemotherapeutic strategy
    Yongkyu Lee
    Jehyung Lee
    Changbaek Lim
    Food Science and Biotechnology, 2021, 30 : 321 - 340
  • [26] Research Progress in Flavonoids as Potential Anticancer Drug Including Synergy with Other Approaches
    Hussain, Yusuf
    Luqman, Suaib
    Meena, Abha
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (20) : 1791 - 1809
  • [27] Anticancer activity of flavonoids accompanied by redox state modulation and the potential for a chemotherapeutic strategy
    Lee, Yongkyu
    Lee, Jehyung
    Lim, Changbaek
    FOOD SCIENCE AND BIOTECHNOLOGY, 2021, 30 (03) : 321 - 340
  • [28] Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties
    Galati, G
    O'Brien, PJ
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (03) : 287 - 303
  • [29] Potential anticancer role of colchicine-based derivatives: an overview
    Kumar, Ashok
    Sharma, Parduman R.
    Mondhe, Dilip M.
    ANTI-CANCER DRUGS, 2017, 28 (03) : 250 - 262
  • [30] Flavonoids: Promising anticancer agents
    Ren, WY
    Qiao, ZH
    Wang, HW
    Zhu, L
    Zhang, L
    MEDICINAL RESEARCH REVIEWS, 2003, 23 (04) : 519 - 534